Dumping Syndrome Market Research Report - Global Forecast till 2023

Dumping Syndrome Market Research Report - Global Forecast till 2023

ID: MRFR/HC/3879-HCRR | | Region: Global | 115 pages | Half-Cooked Research Reports

Dumping Syndrome Market Research Report: By Diagnosis (Blood Sugar Test, Gastric Emptying Test, Medical History), By Treatment (Medication, Surgery), By End User (Hospitals & Clinics, Research Laboratories, Diagnostic Centers) – Global forecast till 2023   


Market Scenario


Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping syndrome occurs after gastric bypass surgery. According to the University of Rochester Medical Center, the dumping syndrome can happen in at least 3 out of 20 patients who have had a part of their stomach removed for any reason.


Mostly, people with dumping syndrome develop signs and symptoms, such as abdominal cramps and diarrhea, 10 to 30 minutes after eating. Whereas in some cases people have symptoms one to three hours after eating, few have also reported having both early and late symptoms. Early signs and symptoms include nausea, vomiting, abdominal cramps, diarrhea flushing, dizziness, lightheadedness, and rapid heart rate whereas, late signs and symptoms include sweating, hunger, fatigue, dizziness, lightheadedness, weakness, and rapid heart rate. The rising prevalence of upper GI diseases, changing lifestyle, and increasing demand for minimally invasive surgery are major drivers for the growth of the market across the globe. Additionally, use of technologically advanced devices for a surgical procedure in healthcare institutes also influence the market growth during the forecast period. Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries lead the globalization by pushing new products and services into the developing countries and emerging economies. On the other hand, side effects of dumping syndrome may hamper the market growth during the forecast period.


The Global Dumping Syndrome Market is expected to grow at a CAGR of ~6.4 % during the forecast period, 2017-2023.

Figure: Global Dumping Syndrome Market, By Region Market Share, 2016 (%)

Dumping Syndrome Market


Sources: Annual reports, Press release, White paper, Company presentation


Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Segmentations


The global dumping syndrome market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of diagnosis, it is segmented into blood sugar test, gastric emptying test, medical history, and others.


Based on the treatment, it is segmented into medication, surgery, and others. Medication is further sub-segmented into imodium, lomotil, prevalite, colestid, welchol, octreotide, and others.


On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.


Key Players


Some of key the players in the market are Medtronic (U.S.), Intuitive Surgical Inc. (U.S.), TransEnterix Inc.  (U.S.), ALLERGAN (Republic of Ireland), USGI Medical Inc. (U.S.), Cousin Biotech (France), GI Dynamics Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Mediflex Surgical Product (U.S.), and others.


Research Methodology

Dumping Syndrome Market 2018


Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The Americas dominate the global dumping syndrome market owing to increasing research & development activities and concentration of major market players boosting the market growth during the forecast period. Moreover, well-developed technology, increasing patient population with upper GI diseases, high healthcare spending, and increasing government support for research & development drive the market growth.


Europe holds the second position in the global dumping syndrome market owing to the government support for research & development and availability of funds for research. For instance, countries like Germany and France are increasing investment in the healthcare domain. Furthermore, this is expected to continue to drive the European market over the forecasted period.      


Asia Pacific is the fastest growing dumping syndrome market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods for gastrointestinal diseases in countries like India and China is likely to emerge as the fastest growing market across the globe. Moreover, increasing demand for quality devices in the healthcare sector is projected to lead to the use of advanced equipment, which in turn, is anticipated to increase the market growth in the region.   


On the other hand, in the Middle East and Africa, limited market share due to gastrointestinal diseases have become a huge problem owing to limited screening, ignorance of diseases, and poor access to the treatment.

Table of Content          

Chapter 1.         Report Prologue           

Chapter 2.         Market Introduction       

2.1        Definition         

2.2        Scope of the Study      

2.2.1     Research Objective      

2.2.2     Assumptions    

2.2.3     Limitations       

Chapter 3.         Research Methodology

3.1        Introduction

3.2        Primary Research         

3.3        Secondary research      

3.4        Market Size Estimation

Chapter 4.         Market Dynamics

4.1        Drivers 

4.2        Restrains

4.3        Opportunities   

4.4        Challenges

4.5        Macroeconomic Indicators

4.6        Technology Trends & Assessment                                

Chapter 5.         Market Factor Analysis

5.1        Porter’s Five Forces Analysis

5.1.1     Bargaining Power of Suppliers  

5.1.2     Bargaining Power of Buyers

5.1.3     Threat of New Entrants 

5.1.4     Threat of Substitutes    

5.1.5     Intensity of Rivalry        

5.2        Value Chain Analysis

5.3        Investment Feasibility Analysis  

5.4        Pricing Analysis

Chapter 6.         Global Dumping Syndrome Market, by Diagnosis

                        6.1        Introduction

6.2        Blood Sugar Test

6.2.1     Market Estimates & Forecast, 2017 – 2023

6.3        Gastric Emptying Test

6.3.1     Market Estimates & Forecast, 2017 – 2023

Chapter 7.         Global Dumping Syndrome Market, by Treatment

7.1        Introduction

7.2        Medication

7.2.1     Market Estimates & Forecast, 2017 – 2023

7.3        Surgery

7.3.1     Market Estimates & Forecast, 2017 – 2023

Chapter 8.         Global Dumping Syndrome Market, by End User

8.1        Introduction

8.2        Hospitals & Clinics

8.2.1     Market Estimates & Forecast, 2017 – 2023

8.3        Research Laboratories

8.3.1     Market Estimates & Forecast, 2017 – 2023

8.4        Others

Chapter 9.         Global Dumping Syndrome Market, by Region

9.1        Introduction

9.2        America

9.2.1     North America

9.2.1.1  U.S.

9.2.1.1  Canada

9.2.2     South America

9.3        Europe

9.3.1     Western Europe

9.3.1.1  Germany

9.3.1.2  France

9.3.1.3  Italy

9.3.1.4  Spain

9.3.1.5  U.K

9.3.1.6  Rest of Western Europe

9.3.2     Eastern Europe

9.4        Asia Pacific

9.4.1     Japan

9.4.2     China

9.4.3     India

9.4.4     Australia

9.4.5     Republic of Korea

9.4.6     Rest of Asia Pacific

9.5        The Middle East & Africa

9.5.1     United Arab Emirates

9.5.2     Saudi Arabia

9.5.3     Oman

9.5.4     Kuwait

9.5.5     Qatar

9.5.6     Rest of the Middle East & Africa

Chapter 10        Company Landscape    

10.1      Introduction      

10.2      Market Share Analysis  

10.3      Key Development & Strategies 

10.3.1   Key Developments       

Chapter 11        Company Profiles        

11.1      Medtronic

11.1.1   Company Overview      

11.1.2   Product Overview         

11.1.3   Financials        

11.1.4   SWOT Analysis

11.2      Intuitive Surgical Inc      

11.2.1   Company Overview      

11.2.2   Product Overview         

11.2.3   Financial Overview        

11.2.4   Key Developments       

11.2.5   SWOT Analysis

11.3      TransEnterix Inc

11.3.1   Company Overview      

11.3.2   Product Overview         

11.3.3   Financial Overview

11.3.4   Key Development         

11.3.5   SWOT Analysis

11.4      ALLERGAN

11.4.1   Company Overview      

11.4.2   Product /Business Segment Overview   

11.4.3   Financial Overview        

11.4.4   Key Development         

11.4.5   SWOT Analysis

11.5      USGI Medical Inc

11.5.1   Company Overview      

11.5.2   Product Overview         

11.5.3   Financial overview        

11.5.4   Key Developments       

11.6      Cousin Biotech 

11.6.1   Company Overview      

11.6.2   Product Overview         

11.6.3   Financial Overview        

11.6.4   Key Developments       

11.7      GI Dynamics Inc

11.7.1   Overview          

11.7.2   Product Overview         

11.7.3   Financials        

11.7.4   Key Developments       

11.7.5   SWOT Analysis

                        11.8      Others

Chapter 12        MRFR Conclusion        

12.1      Key Findings    

12.1.1   From CEO’s View Point

12.1.2   Unmet Needs of the Market      

12.2      Key Companies to Watch         

12.3      Prediction of Healthcare industry

Chapter 13        Appendix

 

LIST OF TABLES

Table 1             Dumping Syndrome Industry Synopsis, 2017 – 2023

Table 2             Global Dumping Syndrome Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3             Global Dumping Syndrome Market by Region, 2017 – 2023, (USD Million)

Table 4             Global Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 5             Global Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 6             Global Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 7             North America Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 8             North America Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 9             North America Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 10            US Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 11            US Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 12            US Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 13            Canada Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 14            Canada Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 15            Canada Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 16            South America Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 17            South America Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 18            South America Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 19            Europe Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 20            Europe Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 21            Europe Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 22            Western Europe Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 23            Western Europe Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 24            Western Europe Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 25            Eastern Europe Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 26            Eastern Europe Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 27            Eastern Europe Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 28            Asia Pacific Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 29            Asia Pacific Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 30            Asia Pacific Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

Table 31            Middle East & Africa Dumping Syndrome Market by Diagnosis, 2017 – 2023, (USD Million)

Table 32            The Middle East & Africa Dumping Syndrome Market by Treatment, 2017 – 2023, (USD Million)

Table 33            The Middle East & Africa Dumping Syndrome Market by End Users, 2017 – 2023, (USD Million)

 

LIST OF FIGURES

 

Figure 1            Research Process


Figure 2            Segmentation for Global Dumping Syndrome Market

Figure 3            Segmentation Market Dynamics for Global Dumping Syndrome Market

Figure 4            Global Dumping Syndrome market Share, by Diagnosis 2016

Figure 5            Global Dumping Syndrome market Share, by Treatment 2016

Figure 6            Global Dumping Syndrome Market Share, by End Users, 2016

Figure 7            Global Dumping Syndrome Market Share, by Region, 2016

Figure 8            North America Dumping Syndrome Market Share, by Country, 2016

Figure 9            Europe Dumping Syndrome Market Share, by Country, 2016

Figure 10          Asia Pacific Dumping Syndrome Market Share, by Country, 2016

Figure 11          Middle East & Africa Dumping Syndrome Market Share, by Country, 2016

Figure 12          Global Dumping Syndrome Market: Company Share Analysis, 2016 (%)

Figure 13          Medtronic: Key Financials

Figure 14          Medtronic: Segmental Revenue

Figure 15          Medtronic: Geographical Revenue

Figure 16          Intuitive Surgical Inc.: Key Financials

Figure 17          Intuitive Surgical Inc.: Segmental Revenue

Figure 18          Intuitive Surgical Inc.: Geographical Revenue

Figure 19          TransEnterix Inc.: Key Financials

Figure 20          TransEnterix Inc.: Segmental Revenue

Figure 21          TransEnterix Inc.: Geographical Revenue

Figure 22          ALLERGAN: Key Financials

Figure 23          ALLERGAN: Segmental Revenue

Figure 24          ALLERGAN: Geographical Revenue

Figure 25          USGI Medical Inc.: Key Financials

Figure 26          USGI Medical Inc: Segmental Revenue

Figure 27          USGI Medical Inc: Geographical Revenue

Figure 28          Cousin Biotech..: Key Financials

Figure 29          Cousin Biotech.: Segmental Revenue

Figure 30          Cousin Biotech..: Geographical Revenue

Figure 31          GI Dynamics Inc.: Key Financials

Figure 32          GI Dynamics Inc.: Segmental Revenue

Figure 33          GI Dynamics Inc.: Geographical Revenue